Board changes

RNS Number : 5357Q
Genesis Emerging Markets Fund Ld
19 June 2020
 

Genesis Emerging Markets Fund Limited ('the Fund')

Legal Entity Identifier: 213800HWWQPUJ4K1GS84

 

 

Board changes

 

In accordance with Listing Rule 9.6.13, the Board is pleased to announce the appointment of Mr Torsten Koster as an independent non-executive director of the Fund with effect from 1st July 2020. Torsten's appointment will be subject to formal shareholder approval at the Fund's forthcoming Annual General Meeting on 4th November 2020.

 

Torsten has over 30 years' experience working for large multi-national companies. He spent two spells at Nestle SA (1991-1997 and 2003-2016). During his second spell he held the positions of Chief Financial Officer Nestle Russia & Eurasia (2007-2011) and Chief Financial Officer Nestle Nespresso SA (2011-2016). He also held the positions of Chief Financial Officer at Lukoil SA (1998-200) and Elca Informatique SA (2000-2003). In 2016 Torsten started his own consultancy business, Baussann Concept SA providing due diligence and portfolio services to European and US based private equity firms. He was a board member of SodaStream International (2016-2018) (NASDAQ:SODA) and is currently a board member of Banque Heritage SA and Natra SA (both of which are unlisted entities). He holds a Masters degree from HEC Lausanne.

 

Also, In accordance with Listing Rule 9.6.13, the Board announces that, having served for nine years, Mr Saffet Karpat will retire from his position as a non-executive director of the Fund after the 2020 Annual General Meeting.

 

There are no other details to be disclosed under paragraph 9.6.13 of the Listing Rules of the UK Listing Authority.

 

 

For further information, please contact:

 

J.P. Morgan Administration Services (Guernsey) Limited

Company Secretary

01481 758 620

 

19th June 2020

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAFLMBTMTTBBFM
UK 100

Latest directors dealings